Previda®-DX

Previda^®-DX

Monogenic/Single Gene Disorders (PGT-M) &
Chromosomal Structural Rearrangements (PGT-SR)

Who Should Consider Previda^®-DX?

Previda^®-DX is designed to identify single gene defects in embryos prior to implantation. Single gene disorders are genetic conditions caused by a change or mutation in a specific gene. Individuals with a family history of a genetic condition may be at risk of passing the condition on to their children.

Preimplantation genetic testing for monogenic/single gene disorders (PGT-M) is recommended for parents undergoing IVF who are at high risk of passing a genetic condition to their offspring. Your results from the Previda^®-DX test can allow your physician to select and transfer the embryo that is free of a specific single gene mutation.

Examples of common single gene disorders include:

Cystic fibrosis
Sickle cell anemia
Tay-Sachs disease

Couples that have experienced recurrent miscarriages or unsuccessful pregnancies may be carriers of chromosomal structural rearrangements (translocations). In these cases, Previda^®-DX can help reduce the risk of miscarriage by screening for embryos with unbalanced translocations and selecting embryos with a normal karyotype.

Find out if Previda^®-DX is right for you.

Progenesis Inc.
Address: 4150 Regents Park Row,
Suite 245,
La Jolla, CA 92037

Phone: (858) 257-2122
Fax: (888) 810-6079

About Progenesis

Progenesis is a San Diego based company that develops and offers genetic testing services for patients throughout their family planning journey. Progenesis was the first company in the U.S. to offer Next Generation Sequencing (NGS) for preimplantation genetic testing. Through optimization of the NGS platform, Progenesis confidently maintains the most accurate testing in the IVF field with the lowest rate of mosaicism.